摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside | 117253-26-6

中文名称
——
中文别名
——
英文名称
2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside
英文别名
2-(trimethylsilyl)ethyl (2,3,6-tri-O-benzyl)-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside;2-(trimethylsilyl)ethyl 2,3,6-tri-O-benzyl-β-D-galactopyranosyl-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside;2-(trimethylsilyl)ethyl 2,3,6-tri-O-benzyl-4-O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside;Bn(-2)[Bn(-3)][Bn(-6)]Gal(b1-4)[Bn(-2)][Bn(-3)][Bn(-6)]Glc(b)-O-EtTMS;(2R,3S,4S,5R,6S)-6-[(2R,3R,4S,5R,6R)-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-(2-trimethylsilylethoxy)oxan-3-yl]oxy-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-ol
2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside化学式
CAS
117253-26-6
化学式
C59H70O11Si
mdl
——
分子量
983.284
InChiKey
GGTURERSSXDCLN-IGFJTUNPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.31
  • 重原子数:
    71
  • 可旋转键数:
    26
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    113
  • 氢给体数:
    1
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of the globotetraose tetrasaccharide and terminal tri- and di-saccharide fragments
    作者:Ulf Nilsson、Asim K. Ray、Göran Magnusson
    DOI:10.1016/0008-6215(94)90010-8
    日期:1994.1
    groups. Removal of the anomeric TMSEt group of the globotetraoside and of the terminal trisaccharide, using trifluoroacetic acid-dichloromethane, gave the corresponding hemiacetal sugars 8 and 3. The TMSEt glycoside of the terminal trisaccharide was converted, via the 1-acetate, into the corresponding isobutyl (4) and 3-butylsulfonyl-2-[(butylsulfonyl)methyl]propyl (5) glycosides and into the TMSEt thioglycoside
    球四糖[β-D-GalNAc-(1-> 3)-alpha-D-Gal-(1-> 4)-beta-D-Gal-的2-(三甲基甲硅烷基)乙基(TMSEt)β-糖苷(1-> 4)-D-Glc]和末端三糖,以及末端二糖的甲基α-糖苷1,是由三氟甲磺酸银促进适当保护的半乳糖苷,galabioside和globotrioside的β-糖基化合成的醇与3,4,6-三-O-乙酰基-2-脱氧-2-邻苯二甲酰亚胺基-β-D-吡喃半乳糖苷氯,然后除去保护基。用三氟乙酸-二氯甲烷除去三糖四糖苷和末端三糖的异头TMSEt基团,得到相应的半缩醛糖8和3。末端三糖的TMSEt糖苷通过1-乙酸盐转化,
  • Synthetic Studies on Sialoglycoconjugates 82: First Total Synthesis of Sialyl Globopentaosyl Ceramide (V<sup>3</sup>Neu5AcGb5Cer) and its Positional Isomer (V<sup>6</sup>Neu5AcGb5Cer)<sup>1,2</sup>
    作者:Hideharu Ishida、Ryuichi Miyawaki、Makoto Kiso、Akira Hasegawa
    DOI:10.1080/07328309608005436
    日期:1996.2
    Abstract The first, total synthesis of sialyl globopentaosyl ceramide (V3Neu5AcGb5Cer) and its positional isomer (V6Neu5AcGb5Cer) are described. α-Selective glycosylation of 2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside (7) with the suitably protected galactose donor, methyl 3-O-acetyl-2-O-benzyl-4,6-O-benzylidene-l-thio-β-D-galactopyranoside
    摘要首先介绍了唾液酸球型戊二糖基神经酰胺(V3Neu5AcGb5Cer)及其位置异构体(V6Neu5AcGb5Cer)的全合成。2-(三甲基甲硅烷基)乙基O-(2,3,6-三-O-苄基-β-D-吡喃半乳糖基)-(1→4)-2,3,6-三-O-苄基的α-选择性糖基化-β-D-吡喃葡萄糖苷(7)与适当保护的半乳糖供体,甲基3-O-乙酰基-2-O-苄基-4,6-O-亚苄基-1-硫代-β-D-吡喃半乳糖苷得到所需的三糖通过除去O-乙酰基,将其转化为三糖受体。用甲基3-O-乙酰基-4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚胺基-1-硫代-β-D-吡喃半乳糖苷对该受体进行糖基化,得到了球四糖衍生物,该衍生物经以下反应转化为受体12。除去邻苯二甲酰基和O-乙酰基,然后进行N-乙酰化。
  • Systematic synthesis and MAG-binding activity of novel sulfated GM1b analogues as mimics of Chol-1 (α-series) gangliosides: highly active ligands for neural siglecs
    作者:Hiromi Ito、Hideharu Ishida、Brian E Collins、Susan E Fromholt、Ronald L Schnaar、Makoto Kiso
    DOI:10.1016/s0008-6215(03)00245-3
    日期:2003.7
    Systematic synthesis and myelin-associated glycoprotein (MAG)-binding activity of novel sulfated GM1b analogues structurally related to Chol-1 (alpha-series) gangliosides, high-affinity ligands for neural siglecs, are described. The suitably protected gangliotriose derivatives, 2-(trimethylsilyl)ethyl 2-acetamido-2-deoxy-6-O-levulinoyl-beta-D-galactopyranosyl-(1-->4)-2,3,6-tri-O-benzyl-beta-D-gala
    描述了与Chol-1(α系列)神经节苷脂(神经信号的高亲和力配体)结构相关的新型硫酸化GM1b类似物的系统合成和髓鞘相关糖蛋白(MAG)结合活性。适当保护的神经节三糖衍生物2-(三甲基甲硅烷基)乙基2-乙酰氨基-2-脱氧-6-O-乙酰丙酰基-β-D-吡喃半乳糖基-(1→4)-2,3,6-tri-O-苄基-β-D-吡喃半乳糖基-(1→4)-2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷和2-(三甲基甲硅烷基)乙基2-乙酰氨基-2-脱氧-6- O-乙酰丙酰基-β-D-吡喃半乳糖基-(1-> 4)-2,6-二-O-苄基-3-O-乙酰丙酰基-β-D-吡喃半乳糖基-(1-> 4)-2, 3,6-tri-O-苄基-β-D-吡喃葡萄糖苷分别用α-NeuAc-(2-> 3)-半乳糖供体糖基化,得到相应的五糖,分别为94%(仅β1,3糖苷)和90% %(beta1,3:beta1,4 = 2:1),分别。在
  • Regio- and stereo-selective synthesis of ganglioside GM1b and some positional analogs
    作者:Hubli Prabhanjan、Akihiko Kameyama、Hideharu Ishida、Makoto Kiso、Akira Hasegawa
    DOI:10.1016/0008-6215(91)80011-b
    日期:1991.11
    Total syntheses of ganglioside GM1b (IV3NeuAcGgOse4Cer) and three of its positional analogs are described. Methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D- glycero-alpha-D-galacto-2-nonulopyranosylonate)- (2----3)-2,4,6-tri-O-benzoyl-1-thio-beta-D-galactopyranoside (7) and methyl O-(methyl 5- acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-2 -nonulopyranosylonate)-(2----6)-2
    描述了神经节苷脂GM1b(IV3NeuAcGgOse4Cer)及其三个位置类似物的总合成。O-(5-乙酰氨基-4,7,8,9-四-O-乙酰基-3,5-二甲氧基-D-甘油-α-D-半乳糖-2-壬基吡喃糖醛酸甲酯)-(2 ---- 3)-2,4,6-三-O-苯甲酰基-1-硫代-β-D-吡喃半乳糖苷(7)和甲基O-(甲基5-乙酰氨基-4,7,8,9-四-O-乙酰基-3,5-二脱氧-D-甘油-α-D-半乳糖-2-壬基吡喃磺酸盐)-(2 ---- 6)-2,4-二-O-苯甲酰基-3-O-苄基-1-硫代-β-D-吡喃半乳糖苷(8)是根据我们报道的方法制备的关键糖基供体。3,4,6-三-O-乙酰基-2-脱氧-2-邻苯二甲酰亚胺基-α-D-吡喃半乳糖基溴化物与2-(三甲基甲硅烷基)乙基O-(2,3,6-三-O-苄基- β-D-吡喃半乳糖基)-(1 ---- 4)-2,3,6-三-O-苄基-β-D-吡喃葡萄
  • A HIGHLY EFFICIENT TOTAL SYNTHETIC ROUTE TO α-SERIES GANGLIOSIDES: GM1α, GD1α, AND GT1α1-2
    作者:Hiromi Ito、Hideharu Ishida、Makoto Kiso
    DOI:10.1081/car-100103959
    日期:2001.3.31
    A highly efficient total synthetic route to alpha -series gangliosides GM1 alpha, GD1 alpha and GT1 alpha is described. The suitably protected gangliotriose (GgOse3) derivatives, i.e., 2-(trimethylsilyl)ethyl (2-acetamido-2-deoxy-3-O-p-methoxybenzyl-beta -D-galactopyranosyl)-(1-->4)-(2,3,6-tri-O-benzyl-beta -D-galactopyranosyl)-(1 -->4)-2,3,6-tri-O-benzyl-beta -D-glucopyranoside (8) and the corresponding III3-levulinoyl derivative (9), were regioselectively glycosylated with the phenyl 2-thioglycoside of N-acetylneuraminic acid (Neu5Ac) promoted by N-iodosuccinimide (NIS)-trimethylsilyl trifluoromethanesulfonate (TMSOTf) or trifluoromethanesulfonic acid (TfOH) in acetonitrile, to give the desired alpha -Neu5Ac-(2-->6)-gangliotriose (III(6)Neu5AcGgOse3) derivatives as the major products (11 and 12). The p-methoxybenzyl (MPM) group in 11 or the levulinoyl group in 12 was selectively removed, and the resulting 2-(trimethylsilyl)ethyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-alpha -D-galacto-2-nonulopyranosylonate)-(2-->6)-(2-acetamido-2-deoxy-beta -D-galactopyranosyl)-(1-->4)-(2,3,6-tri-O-benzyl-beta -D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl-beta -D-glucopyranoside (13), a key glycosyl acceptor, was systematically glycosylated with the galactose donor (14), alpha -Neu5Ac-(2-->3)-galactuse donor (15) and alpha -Neu5Ac-(2-->8)-alpha -Neu5Ac-(2-->3)-galactose donor (20) to give the protected GM1 alpha (16, 70%), GD1 alpha (17, 80%) and GT1 alpha (21, 87%) oligosaccharides, respectively, which can be converted to the target gangliosides by the introduction of ceramide and then complete deprotection.
查看更多